Abstract:Objective: Synergistic drug combinations are promising therapies for cancer treatment. However, effective prediction of synergistic drug combinations is quite challenging as mechanisms of drug synergism are still unclear. Various features such as drug response, and target networks may contribute to prediction of synergistic drug combinations. In this study, we aimed to construct a computational model to predict synergistic drug combinations. Methods: We designed drug physicochemical features and network features, including drug chemical structure similarity, target distance in protein-protein network and targeted pathway similarity. At the same time, we designed fifteen pharmacogenomics features using drug treated gene expression profiles based on the background of cancer-related biology network. Based on these eighteen features, we built a prediction model for Synergistic Drug combination using Random forest algorithm (SyDRa). Results: Our model achieved a quite good performance with AUC value of 0.89 and Out-of-bag estimate error rate of 0.15 in training dataset. Using the random anti-cancer drug combinations which have transcriptional profile data in the Connectivity Map dataset as the testing dataset, we identified 28 potentially synergistic drug combinations, three out of which had been reported to be effective drug combinations by literatures. Conclusions: We studied eighteen features for drug combinations and built a computational model using random forest algorithm. The model was evaluated using an independent test dataset. Our model provides an efficient strategy to identify potentially synergistic drug combinations for cancer and may help reduce the search space for high-throughput synergistic drug combinations screening. (C) 2017 Elsevier B.V. All rights reserved.

Searching Synergistic Dose Combinations for Anticancer Drugs

Advances in computational approaches in identifying synergistic drug combinations.

Drug Combination in Clinical Cancer Treatments

A streamlined search technology for identification of synergistic drug combinations

Optimized Combinations of Bortezomib, Camptothecin, and Doxorubicin Show Increased Efficacy and Reduced Toxicity in Treating Oral Cancer.

Developing an Agent-Based Drug Model to Investigate the Synergistic Effects of Drug Combinations

A Bayesian Dose Finding Design for Oncology Clinical Trials of Combinational Biological Agents

Prediction of Synergistic Anti-Cancer Drug Combinations Based on Drug Target Network and Drug Induced Gene Expression Profiles

Effective drug combinations in breast, colon and pancreatic cancer cells

Bayesian Dose Finding for Combined Drugs with Discrete and Continuous Doses

Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer

Exploration of the Use of Natural Compounds in Combination with Chemotherapy Drugs for Tumor Treatment

Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs

Search Algorithms as a Framework for the Optimization of Drug Combinations

CCSynergy: an integrative deep-learning framework enabling context-aware prediction of anti-cancer drug synergy

Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation

Anticancer drugs: How to select small molecule combinations?

Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin

A review of machine learning approaches for drug synergy prediction in cancer

Rational combinations of targeted cancer therapies: background, advances and challenges

Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer